Takamasa Horio

Practice Areas

Life Sciences, Crisis Management, Mergers and Acquisitions, General Corporate.

Career

Joined Mori Hamada & Matsumoto in 2010, becoming Partner in 2022. Worked with Jenner & Block LLP, Chicago (2016-2017). Seconded to the Pharmaceutical Safety and Environmental Health Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare (2017-2020).

Professional Memberships

Admitted in Japan, 2009; Illinois, 2016.

Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology, Japan Agency for Medical Research and Development (2020-2022); Member of Study Group on Countermeasures against Cannabis and Other Drugs, Ministry of Health, Labour and Welfare(2020-2021); Member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council (2021), Member of the Toyama Prefecture GMP Inspection Investigative Committee (2021); Member of Research for Identifying Issues Relating to Determinations on Whether Programs Constitute Medical Devices Based on International Consistency, a Special Scientific Research Project Sponsored by the MHLW (2021-2022); Adviser for The Japan Federation of Medical Devices Associations (2021-); Member of Legislation Committee, Japan Pharmaceutical Association (2022-); Member of the Board of Experts for the "Consultation Desk for Clinical Research of Medical Equipment," Japan Association for the Advancement of Medical Equipment (2024-); Member of the Examination Committee on Technologies for Welfare and Medical Care with Smart Robots, a Moonshot Research and Development Program, Japan Science and Technology Agency (2024-).

Publications

“Legal Commentary: the Pharmaceuticals and Medical Devices Act”, Shojihomu, 2021; “Q&A: Digital Health and Law [2nd ed.]”, Shojihomu, 2022; "Case Studies and Key Points for Entry to the Health Care Industry by Companies of Different Business Categories (Part 1-8), Business Houmu, 2022-2023; “ Practical Responses Based on the Revised Pharmaceuticals and Medical Devices Act (Enforcement Date: August 1, 2021) (1), (2)”, NBL, 2021; "Chambers Global Practice Guides Medical Cannabis and Cannabinoid Regulation 2023 - Japan Trends and Developments", Chambers Global Practice Guides Medical Cannabis and Cannabinoid Regulation 2023, 2023; "Q&A: Legal Affairs in Specific Types of Business - Medical Devices", Chuokeizai-sha, 2024; "Q&A: Legal Affairs in Specific Types of Business - Pharmaceuticals", Chuokeizai-sha, 2024; "MR Textbook 2024", Nanzando, 2024.

Personal

Graduated from Kyoto University Law School (J.D., 2008), Northwestern University Pritzker School of Law (LL.M., 2016) and Kellogg School of Management (Certificate in Business Administration, 2016).